• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Renal sympathetic denervation for treatment of resistant hypertension - indigenous technique.肾交感神经去神经术治疗顽固性高血压——本土技术
Indian Heart J. 2013 May-Jun;65(3):239-42. doi: 10.1016/j.ihj.2013.04.030. Epub 2013 Apr 19.
2
Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.第二代EnligHTN™肾去神经支配系统在耐药性、未控制高血压患者中的安全性和性能。
Atherosclerosis. 2017 Jul;262:94-100. doi: 10.1016/j.atherosclerosis.2017.04.022. Epub 2017 May 3.
3
[Renal denervation a treatment for resistant hypertension: a French experience].[肾去神经术治疗顽固性高血压:法国的经验]
Ann Cardiol Angeiol (Paris). 2013 Dec;62(6):384-91. doi: 10.1016/j.ancard.2013.09.003. Epub 2013 Oct 12.
4
Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.采用标准电生理导管的药物抵抗性高血压的导管相关肾脏去神经术。
EuroIntervention. 2012 Jan;7(9):1077-80. doi: 10.4244/EIJV7I9A171.
5
Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?使用灌注导管对顽固性高血压患者进行肾去神经支配:一种有前景的策略?
Arq Bras Cardiol. 2014 Apr;102(4):355-63. doi: 10.5935/abc.20140034. Epub 2014 Feb 17.
6
Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.经导管去肾交感神经术治疗耐药性高血压:降压效果可持续 24 个月。
Hypertension. 2011 May;57(5):911-7. doi: 10.1161/HYPERTENSIONAHA.110.163014. Epub 2011 Mar 14.
7
Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.基于导管的肾去神经术治疗顽固性高血压患者:SYMPLICITY HTN-2随机临床试验的36个月结果
Eur Heart J. 2014 Jul;35(26):1752-9. doi: 10.1093/eurheartj/ehu209. Epub 2014 Jun 4.
8
Transradial renal denervation for the treatment of resistant hypertension.经桡动脉肾去神经术治疗顽固性高血压
J Invasive Cardiol. 2014 Jul;26(7):322-7.
9
Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.肾交感神经去神经术对难治性高血压合并睡眠呼吸暂停患者血压、睡眠呼吸暂停病程和血糖控制的影响。
Hypertension. 2011 Oct;58(4):559-65. doi: 10.1161/HYPERTENSIONAHA.111.173799. Epub 2011 Aug 15.
10
Catheter-based renal denervation for treatment of resistant hypertension.基于导管的肾去神经术治疗顽固性高血压。
Dan Med J. 2012 Jun;59(6):A4439.

引用本文的文献

1
Safety and feasibility of transcatheter renal sympathetic denervation using different types of catheter and various radiofrequency settings.使用不同类型导管及各种射频设置进行经导管肾交感神经去神经术的安全性和可行性。
Int J Cardiol Heart Vasc. 2016 Mar 17;11:35-42. doi: 10.1016/j.ijcha.2016.03.008. eCollection 2016 Jun.
2
Renal denervation in a patient with Alport syndrome and rejected renal allograft.一位患有Alport综合征且肾移植被排斥患者的肾去神经支配术。
Indian Heart J. 2015 Dec;67 Suppl 3(Suppl 3):S71-3. doi: 10.1016/j.ihj.2015.12.004. Epub 2015 Dec 20.
3
Renal sympathetic denervation using an externally irrigated radiofrequency ablation catheter for treatment of resistant hypertension - Acute safety and short term efficacy.使用外部冲洗式射频消融导管进行肾交感神经去支配术治疗顽固性高血压——急性安全性和短期疗效
Indian Heart J. 2015 May-Jun;67(3):207-13. doi: 10.1016/j.ihj.2015.02.020. Epub 2015 May 21.

本文引用的文献

1
Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.采用标准电生理导管的药物抵抗性高血压的导管相关肾脏去神经术。
EuroIntervention. 2012 Jan;7(9):1077-80. doi: 10.4244/EIJV7I9A171.
2
Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.经导管去肾交感神经术治疗耐药性高血压:降压效果可持续 24 个月。
Hypertension. 2011 May;57(5):911-7. doi: 10.1161/HYPERTENSIONAHA.110.163014. Epub 2011 Mar 14.
3
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.治疗抵抗性高血压患者的肾脏去神经支配(Symplicity HTN-2 试验):一项随机对照试验。
Lancet. 2010 Dec 4;376(9756):1903-9. doi: 10.1016/S0140-6736(10)62039-9. Epub 2010 Nov 17.
4
Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.肾去神经支配作为高血压的一种治疗方法:对一个旧概念的新启示。
Hypertension. 2009 Dec;54(6):1195-201. doi: 10.1161/HYPERTENSIONAHA.109.138610. Epub 2009 Oct 12.
5
Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.人类高血压中交感神经对心血管驱动的评估:成就与展望。
Hypertension. 2009 Oct;54(4):690-7. doi: 10.1161/HYPERTENSIONAHA.108.119883. Epub 2009 Aug 31.
6
Renal sympathetic-nerve ablation for uncontrolled hypertension.肾交感神经消融术治疗难治性高血压。
N Engl J Med. 2009 Aug 27;361(9):932-4. doi: 10.1056/NEJMc0904179.
7
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.基于导管的肾交感神经去支配术治疗顽固性高血压:一项多中心安全性及原理验证队列研究。
Lancet. 2009 Apr 11;373(9671):1275-81. doi: 10.1016/S0140-6736(09)60566-3. Epub 2009 Mar 28.
8
Resistant hypertension: an overview of evaluation and treatment.顽固性高血压:评估与治疗概述
J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036.
9
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.顽固性高血压:诊断、评估与治疗:美国心脏协会高血压研究理事会专业教育委员会的科学声明
Circulation. 2008 Jun 24;117(25):e510-26. doi: 10.1161/CIRCULATIONAHA.108.189141.
10
Clinical practice. Resistant or difficult-to-control hypertension.临床实践。难治性或难以控制的高血压。
N Engl J Med. 2006 Jul 27;355(4):385-92. doi: 10.1056/NEJMcp041698.

肾交感神经去神经术治疗顽固性高血压——本土技术

Renal sympathetic denervation for treatment of resistant hypertension - indigenous technique.

作者信息

Manakshe Gajendra, Chakravarthi R, Hussaini Shaista, Menon Rajeev, Srinivas Kumar A, Ravi Kiran V, Sundar Gomathi, Narasimhan C

机构信息

Department of Cardiology, CARE Hospital and Research Institute, Hyderabad, India.

出版信息

Indian Heart J. 2013 May-Jun;65(3):239-42. doi: 10.1016/j.ihj.2013.04.030. Epub 2013 Apr 19.

DOI:10.1016/j.ihj.2013.04.030
PMID:23809374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3860960/
Abstract

BACKGROUND

The endovascular approach of ablation of renal sympathetic nerves is found to be effective in the treatment of uncontrolled hypertension. We report here our experience with the procedure in eight patients with drug resistant hypertension.

METHODS

We included patients in whom the blood pressure remained above 150/90 mmHg despite being on minimum three antihypertensive drugs. Radiofrequency ablation of the sympathetic nerves of both the renal arteries was done using conventional ablation catheters. The patients were followed at 1-month, 3 months and 6 months post procedure and blood pressure recorded.

RESULTS

All patients underwent successful renal sympathetic denervation. The mean blood pressure of the patients was 181/102.5 mmHg before the procedure and the average requirement of antihypertensive drugs per day was 4. A significant reduction in both systolic and diastolic blood pressure was observed post procedure which sustained over the follow up period of six months. The mean blood pressure observed at 1-month, 3 and 6 months were 137.5/80 mmHg, 136/81 mmHg and 137.5/81 mmHg, respectively. The average requirement of the number of antihypertensives also was reduced to 2.5 at the end of 6 months. There were no procedural complications.

CONCLUSION

Catheter based renal denervation causes substantial and sustained blood pressure reduction without serious adverse events in patients with resistant hypertension.

摘要

背景

肾交感神经消融的血管内治疗方法被发现对治疗难治性高血压有效。我们在此报告我们对8例耐药性高血压患者进行该手术的经验。

方法

我们纳入了尽管使用了至少三种抗高血压药物但血压仍保持在150/90 mmHg以上的患者。使用传统消融导管对双侧肾动脉的交感神经进行射频消融。在术后1个月、3个月和6个月对患者进行随访并记录血压。

结果

所有患者均成功进行了肾交感神经去神经支配。患者术前平均血压为181/102.5 mmHg,每天平均需要4种抗高血压药物。术后观察到收缩压和舒张压均显著降低,且在6个月的随访期内持续存在。在1个月、3个月和6个月时观察到的平均血压分别为137.5/80 mmHg、136/81 mmHg和137.5/81 mmHg。6个月末抗高血压药物的平均使用数量也减少到了2.5种。没有手术并发症。

结论

对于耐药性高血压患者,基于导管的肾去神经支配可显著且持续地降低血压,且无严重不良事件。